Atlas Trials

A Study To Evaluate the Safety of XW001 Inhalation in Children With RSV

Clinical trial NCT05779995 · COMPLETED

Trial details

NCT number
NCT05779995
Sponsor
Hangzhou Sciwind Biosciences Co., Ltd.
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
RSV Infection
Start date
2023-04-20
Primary completion
2023-10-10
Enrollment
61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.